The scientific community has issued numerous opinions on biosimilars and the process of creating follow-on biologics.

In the right hand column of this page you will find links to background information on this issue from patient advocacy groups, the European commission, and Avalare Health, a healthcare advisory firm.

Also included is testimony from prominent industry experts on ensuring patient safety throughout this process.